v3.26.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2026
Mar. 31, 2026
Sep. 30, 2025
Mar. 31, 2025
Sep. 30, 2026
Sep. 30, 2025
Dec. 31, 2025
CASH FLOWS FROM OPERATING ACTIVITIES:              
Net income (loss) $ 30,231 $ 15,417 $ (1,971) $ (17,421) $ 66,435 $ (6,432)  
Adjustments to reconcile net income (loss) to net cash provided by operating activities:              
Depreciation and amortization of software, equipment, and property         42,120 44,376  
Amortization of intangible assets         68,640 68,641  
Deferred income taxes         17,883 (1,208)  
Stock-based compensation         93,794 146,216  
Amortization of deferred financing fees         1,562 1,405  
Amortization of discount on debt         110 117  
Change in fair value of derivative instruments         (10,019) 8,441  
Noncash interest expense         2,365 1,491  
Changes in:              
Accounts receivable—Net         (5,051) (33,743)  
Deferred contract costs         2,026 (566)  
Other current assets         (2,422) (2,770)  
Deferred contract costs—Non-current         1,655 (1,902)  
Other assets         (3,199) 139  
Operating lease assets         1,789 1,855  
Income taxes         10,482 (30,733)  
Accounts payable         (6,707) 3,813  
Accrued expenses         (364) (6,720)  
Operating lease liabilities         (3,166) (3,277)  
Deferred revenues         (17,875) 10,073  
Other liabilities         (594) (2,901)  
Net cash provided by operating activities         259,464 196,315  
CASH FLOWS FROM INVESTING ACTIVITIES:              
Purchases of software, equipment, and property         (52,966) (46,684)  
Acquisition of EvolutionIQ, Inc., net of cash acquired         0 (410,412)  
Net cash used in investing activities         (52,966) (457,096)  
CASH FLOWS FROM FINANCING ACTIVITIES:              
Proceeds from exercise of stock options         9,314 3,603  
Proceeds from employee stock purchase plan         4,338 5,044  
Payments for employee taxes withheld upon vesting of equity awards         (18,631) (48,262)  
Repurchase of common stock         (100,166) (212,485)  
Proceeds from issuance of long-term debt         0 225,000  
Payments of fees associated with the debt modification         0 (6,565)  
Principal payments on long-term debt         (9,774) (7,508)  
Net cash used in financing activities         (114,919) (41,173)  
NET EFFECT OF EXCHANGE RATE CHANGES ON CASH AND CASH EQUIVALENTS         155 112  
NET CHANGE IN CASH AND CASH EQUIVALENTS         91,734 (301,842)  
Beginning of period   $ 111,192   $ 398,983 111,192 398,983 $ 398,983
End of period $ 202,926   $ 97,141   202,926 97,141 $ 111,192
NONCASH INVESTING AND FINANCING ACTIVITIES:              
Noncash purchases of software, equipment, and property         2,633 0  
Stock issued related the acquisition of EvolutionIQ, Inc.         0 250,441  
Issuance of promissory note to minority investor of redeemable preferred securities         0 22,955  
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION:              
Cash paid for interest         57,637 51,893  
Cash paid for income taxes - Net         $ 9,142 $ 26,199